• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多因素干预降低 2 型糖尿病患者心血管风险的临床可行性和有效性:MIND.IT 研究的 2 年中期分析:一项群组随机试验。

Feasibility and effectiveness in clinical practice of a multifactorial intervention for the reduction of cardiovascular risk in patients with type 2 diabetes: the 2-year interim analysis of the MIND.IT study: a cluster randomized trial.

机构信息

Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy.

出版信息

Diabetes Care. 2013 Sep;36(9):2566-72. doi: 10.2337/dc12-1781. Epub 2013 Jul 17.

DOI:10.2337/dc12-1781
PMID:23863908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3747866/
Abstract

OBJECTIVE

To evaluate the feasibility and effectiveness of an intensive, multifactorial cardiovascular risk reduction intervention in a clinic-based setting.

RESEARCH DESIGN AND METHODS

The study was a pragmatic, cluster randomized trial, with the diabetes clinic as the unit of randomization. Clinics were randomly assigned to either continue their usual care (n = 5) or to apply an intensive intervention aimed at the optimal control of cardiovascular disease (CVD) risk factors and hyperglycemia (n = 4). To account for clustering, mixed model regression techniques were used to compare differences in CVD risk factors and HbA1c. Analyses were performed both by intent to treat and as treated per protocol.

RESULTS

Nine clinics completed the study; 1,461 patients with type 2 diabetes and no previous cardiovascular events were enrolled. After 2 years, participants in the interventional group had significantly lower BMI, HbA1c, LDL cholesterol, and triglyceride levels and significantly higher HDL cholesterol level than did the usual care group. The proportion of patients reaching the treatment goals was systematically higher in the interventional clinics (35% vs. 24% for LDL cholesterol, P = 0.1299; 93% vs. 82% for HDL cholesterol, P = 0.0005; 80% vs. 64% for triglycerides, P = 0.0002; 39% vs. 22% for HbA1c, P = 0.0259; 13% vs. 5% for blood pressure, P = 0.1638). The analysis as treated per protocol confirmed these findings, showing larger and always significant differences between the study arms for all targets.

CONCLUSIONS

A multifactorial intensive intervention in type 2 diabetes is feasible and effective in clinical practice and it is associated with significant and durable improvement in HbA1c and CVD risk profile.

摘要

目的

评估在临床环境中进行强化、多因素心血管风险降低干预的可行性和有效性。

研究设计和方法

这是一项实用的、集群随机试验,以糖尿病诊所为随机单位。诊所被随机分配继续接受常规护理(n = 5)或应用强化干预,旨在最佳控制心血管疾病(CVD)风险因素和高血糖(n = 4)。为了考虑聚类,使用混合模型回归技术比较 CVD 风险因素和 HbA1c 的差异。分析按意向治疗和按方案治疗进行。

结果

9 家诊所完成了研究;纳入了 1461 名患有 2 型糖尿病且无先前心血管事件的患者。2 年后,干预组的参与者 BMI、HbA1c、LDL 胆固醇和甘油三酯水平明显较低,HDL 胆固醇水平明显较高,而常规护理组则明显较低。达到治疗目标的患者比例在干预诊所中系统地更高(LDL 胆固醇分别为 35%比 24%,P = 0.1299;HDL 胆固醇分别为 93%比 82%,P = 0.0005;甘油三酯分别为 80%比 64%,P = 0.0002;HbA1c 分别为 39%比 22%,P = 0.0259;血压分别为 13%比 5%,P = 0.1638)。按方案治疗的分析证实了这些发现,显示出研究臂之间所有目标的差异更大且始终具有统计学意义。

结论

在 2 型糖尿病中进行多因素强化干预在临床实践中是可行且有效的,与 HbA1c 和 CVD 风险状况的显著和持久改善相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e8/3747866/a67fe37d5a42/2566fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e8/3747866/a67fe37d5a42/2566fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e8/3747866/a67fe37d5a42/2566fig1.jpg

相似文献

1
Feasibility and effectiveness in clinical practice of a multifactorial intervention for the reduction of cardiovascular risk in patients with type 2 diabetes: the 2-year interim analysis of the MIND.IT study: a cluster randomized trial.多因素干预降低 2 型糖尿病患者心血管风险的临床可行性和有效性:MIND.IT 研究的 2 年中期分析:一项群组随机试验。
Diabetes Care. 2013 Sep;36(9):2566-72. doi: 10.2337/dc12-1781. Epub 2013 Jul 17.
2
Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.印度一项针对伴发抑郁和糖尿病患者的随机临床试验(INDEPENDENT)表明,协同护理模式可改善抑郁症状及糖化血红蛋白、血压和血清胆固醇水平。
JAMA. 2020 Aug 18;324(7):651-662. doi: 10.1001/jama.2020.11747.
3
The feasibility and efficacy of a community-based multifactorial intervention to improve the cardiovascular risk factor control among patients with type 2 diabetes: A 2-year cluster randomized trial.基于社区的多因素干预改善 2 型糖尿病患者心血管危险因素控制的可行性和疗效:一项为期 2 年的群组随机试验。
Medicine (Baltimore). 2022 Dec 23;101(51):e31943. doi: 10.1097/MD.0000000000031943.
4
Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial.基于临床决策支持系统的团队护理与单纯团队护理对糖尿病患者心血管风险降低的比较效果:D4C 试验的原理和设计。
Am Heart J. 2021 Aug;238:45-58. doi: 10.1016/j.ahj.2021.04.009. Epub 2021 May 4.
5
Effectiveness of the EMPOWER-PAR Intervention in Improving Clinical Outcomes of Type 2 Diabetes Mellitus in Primary Care: A Pragmatic Cluster Randomised Controlled Trial.EMPOWER-PAR干预措施对改善基层医疗中2型糖尿病临床结局的有效性:一项实用性整群随机对照试验
BMC Fam Pract. 2016 Nov 14;17(1):157. doi: 10.1186/s12875-016-0557-1.
6
Intensive multifactorial treatment modifies the effect of family history of diabetes on glycaemic control in people with Type 2 diabetes: a post hoc analysis of the ADDITION-Denmark randomized controlled trial.强化多因素治疗改变2型糖尿病患者家族史对血糖控制的影响:ADDITION-丹麦随机对照试验的事后分析
Diabet Med. 2015 Aug;32(8):1085-9. doi: 10.1111/dme.12764. Epub 2015 Apr 12.
7
Achievement of cardiovascular risk factor targets according to sex and previous history of cardiovascular disease in type 2 diabetes: A population-based study.根据 2 型糖尿病患者的性别和心血管疾病既往史,实现心血管风险因素目标:一项基于人群的研究。
J Diabetes Complications. 2019 Dec;33(12):107445. doi: 10.1016/j.jdiacomp.2019.107445. Epub 2019 Sep 12.
8
Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.亚太地区 2 型糖尿病患者应用技术辅助综合糖尿病护理方案对其代谢相关心血管风险因素的影响:JADE 项目随机临床试验。
JAMA Netw Open. 2021 Apr 1;4(4):e217557. doi: 10.1001/jamanetworkopen.2021.7557.
9
Design and participant characteristics for a randomized effectiveness trial of an intensive lifestyle intervention to reduce cardiovascular risk in adults with type 2 diabetes: The I-D-HEALTH study.一项旨在降低2型糖尿病成年患者心血管风险的强化生活方式干预随机有效性试验的设计及参与者特征:I-D-HEALTH研究
Contemp Clin Trials. 2016 Jan;46:114-121. doi: 10.1016/j.cct.2015.11.016. Epub 2015 Dec 2.
10
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.强化多因素干预对 2 型糖尿病患者心血管结局和死亡的影响(J-DOIT3):一项开放标签、随机对照试验。
Lancet Diabetes Endocrinol. 2017 Dec;5(12):951-964. doi: 10.1016/S2213-8587(17)30327-3. Epub 2017 Oct 24.

引用本文的文献

1
Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.糖尿病护理质量改进策略:对成年糖尿病患者结局的影响。
Cochrane Database Syst Rev. 2023 May 31;5(5):CD014513. doi: 10.1002/14651858.CD014513.
2
Diagnosed diabetes and optimal disease control of prisoners in Catalonia.加泰罗尼亚地区囚犯的糖尿病诊断和最佳疾病控制。
Rev Esp Sanid Penit. 2020 Jan-Apr;22(1):16-22. doi: 10.18176/resp.0003. Epub 2020 Apr 27.
3
The Importance and Role of Multiple Risk Factor Control in Type 2 Diabetes.

本文引用的文献

1
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2型糖尿病高血糖管理:以患者为中心的方法。美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)的立场声明。
Diabetologia. 2012 Jun;55(6):1577-96. doi: 10.1007/s00125-012-2534-0. Epub 2012 Apr 20.
2
Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.女性在 2 型糖尿病和心血管疾病风险因素的控制方面比男性差:来自意大利糖尿病学会 MIND.IT 研究组的结果。
Nutr Metab Cardiovasc Dis. 2013 Mar;23(3):235-41. doi: 10.1016/j.numecd.2011.12.003. Epub 2012 Mar 6.
3
多种危险因素控制在 2 型糖尿病中的重要性和作用。
Curr Cardiol Rep. 2019 Mar 18;21(5):35. doi: 10.1007/s11886-019-1123-y.
4
INTEGRA study protocol: primary care intervention in type 2 diabetes patients with poor glycaemic control.INTEGRA 研究方案:血糖控制不佳的 2 型糖尿病患者的初级保健干预。
BMC Fam Pract. 2019 Feb 7;20(1):25. doi: 10.1186/s12875-019-0916-9.
5
A Narrative Review of Diabetes Intervention Studies to Explore Diabetes Care Opportunities for Pharmacists.一篇关于糖尿病干预研究的叙述性综述,以探索药剂师在糖尿病护理方面的机会。
J Diabetes Res. 2016;2016:5897452. doi: 10.1155/2016/5897452. Epub 2016 May 10.
6
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk.一项关于在2型糖尿病患者一级预防中添加乙酰水杨酸的相关性研究:对一些新出现的心血管风险生物标志物的影响。
Cardiovasc Diabetol. 2015 Jul 30;14:95. doi: 10.1186/s12933-015-0254-8.
7
Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus.2型糖尿病患者心血管疾病风险管理的重要性。
Diabetes Metab Syndr Obes. 2014 May 23;7:169-83. doi: 10.2147/DMSO.S61438. eCollection 2014.
8
Multiple risk factor intervention reduces carotid atherosclerosis in patients with type 2 diabetes.多重危险因素干预可减轻2型糖尿病患者的颈动脉粥样硬化。
Cardiovasc Diabetol. 2014 May 23;13:95. doi: 10.1186/1475-2840-13-95.
IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.国际糖尿病联盟糖尿病地图集:2011 年和 2030 年全球糖尿病患病率估计。
Diabetes Res Clin Pract. 2011 Dec;94(3):311-21. doi: 10.1016/j.diabres.2011.10.029. Epub 2011 Nov 12.
4
Intensive multifactorial intervention improves modelled coronary heart disease risk in screen-detected Type 2 diabetes mellitus: a cluster randomized controlled trial.强化多因素干预可改善筛查出的 2 型糖尿病患者的冠心病风险模型:一项群组随机对照试验。
Diabet Med. 2012 Apr;29(4):531-40. doi: 10.1111/j.1464-5491.2011.03441.x.
5
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.早期强化多因素治疗对筛查出的 2 型糖尿病患者 5 年心血管结局的影响(ADDITION-Europe):一项集群随机试验。
Lancet. 2011 Jul 9;378(9786):156-67. doi: 10.1016/S0140-6736(11)60698-3. Epub 2011 Jun 24.
6
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients.强化降压对糖尿病患者心肌梗死和卒中的影响:73913 例患者的荟萃分析。
J Hypertens. 2011 Jul;29(7):1253-69. doi: 10.1097/HJH.0b013e3283469976.
7
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.在欧洲的临床实践中实现心血管疾病一级预防的治疗目标:EURIKA 研究。
Eur Heart J. 2011 Sep;32(17):2143-52. doi: 10.1093/eurheartj/ehr080. Epub 2011 Apr 6.
8
Patient adherence to medication requirements for therapy of type 2 diabetes.患者对 2 型糖尿病治疗药物要求的依从性。
Int J Clin Pract. 2011 Mar;65(3):314-22. doi: 10.1111/j.1742-1241.2010.02544.x.
9
Standards of medical care in diabetes--2011.《糖尿病医疗护理标准——2011 年》
Diabetes Care. 2011 Jan;34 Suppl 1(Suppl 1):S11-61. doi: 10.2337/dc11-S011.
10
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010".《2009-2010 年意大利糖尿病护理标准》要点
Nutr Metab Cardiovasc Dis. 2011 Apr;21(4):302-14. doi: 10.1016/j.numecd.2010.08.009. Epub 2010 Sep 18.